Vortex Biosciences, Inc.

Vortex Biosciences Inc. , which specializes in circulating tumor cell harvesting for cancer diagnostics, has promoted Chief Technology Officer Bob Englert to the role of Chief Executive Officer. Engle

Device Debuts is a regular Medtech Insight feature highlighting new products introduced into the market for the first time, important new iterations of existing products, or launches of existing pro

Device Debuts highlights brand new products introduced into the market for the first time, as well as important new iterations of existing products, or important product introductions into new geograp

Device Transactions Financing by device companies during the third quarter of 2016 totaled $3 billion, doubling Q2's $1.5 billion. As in the past two quarters, debt offerings continue to make up the h